As of 2026-02-14, the Relative Valuation of Sana Biotechnology Inc (SANA) is (15.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.88 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -498.0%.
The range of the Relative Valuation is (15.14) - (17.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 21.2x | 18.2x |
| Forward P/E multiples | 16.7x - 19.3x | 16.9x |
| Fair Price | (15.14) - (17.02) | (15.44) |
| Upside | -490.1% - -538.6% | -498.0% |
| Date | P/E |
| 2026-02-13 | -4.37 |
| 2026-02-12 | -4.31 |
| 2026-02-11 | -4.41 |
| 2026-02-10 | -4.39 |
| 2026-02-09 | -4.55 |
| 2026-02-06 | -4.47 |
| 2026-02-05 | -4.03 |
| 2026-02-04 | -4.62 |
| 2026-02-03 | -5.01 |
| 2026-02-02 | -5.22 |
| 2026-01-30 | -5.03 |
| 2026-01-29 | -5.23 |
| 2026-01-28 | -5.40 |
| 2026-01-27 | -5.65 |
| 2026-01-26 | -5.42 |
| 2026-01-23 | -5.49 |
| 2026-01-22 | -5.68 |
| 2026-01-21 | -5.41 |
| 2026-01-20 | -5.20 |
| 2026-01-16 | -5.20 |
| 2026-01-15 | -5.31 |
| 2026-01-14 | -5.39 |
| 2026-01-13 | -5.34 |
| 2026-01-12 | -5.20 |
| 2026-01-09 | -5.18 |
| 2026-01-08 | -5.14 |
| 2026-01-07 | -5.37 |
| 2026-01-06 | -4.95 |
| 2026-01-05 | -4.61 |
| 2026-01-02 | -4.76 |
| 2025-12-31 | -4.62 |
| 2025-12-30 | -4.64 |
| 2025-12-29 | -4.68 |
| 2025-12-26 | -5.01 |
| 2025-12-24 | -5.15 |
| 2025-12-23 | -5.15 |
| 2025-12-22 | -5.19 |
| 2025-12-19 | -4.95 |
| 2025-12-18 | -5.11 |
| 2025-12-17 | -5.43 |
| 2025-12-16 | -5.68 |
| 2025-12-15 | -5.77 |
| 2025-12-12 | -5.84 |
| 2025-12-11 | -5.68 |
| 2025-12-10 | -5.61 |
| 2025-12-09 | -4.94 |
| 2025-12-08 | -5.26 |
| 2025-12-05 | -5.83 |
| 2025-12-04 | -5.89 |
| 2025-12-03 | -5.08 |